BioSpace News Archive

Synlogic, Inc. reported its financial results for the first quarter ended March 31, 2019.

Mettler-Toledo International Inc. announced first quarter results for 2019.

Verastem, Inc. reported financial results for the three months ended March 31, 2019.

A new study shows more aggressive treatment may be needed for a large number of patients taking statin medications, and that treatment could help reduce cases of cardiovascular disease, the leading cause of death in the U.S.

RefleXion Medical, a biotargeting oncology company using each cancer’s unique biology as a means to destroy it, today announced the opening of its new manufacturing facility at its headquarters in Hayward, Calif.

Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced a poster presentation at the Society for Investigative Dermatology Meeting, May 8-11, in Chicago.

Demonstrating its advocacy for genomics research, Integrated DNA Technologies (IDT) announces a significant expansion to its NGS portfolio. The company is excited to launch a uniqueCustom NGS Adapters offering, becoming the only genomics provider to provide an easy and flexible customized adapter solution directly to scientists.

SALT LAKE CITY, May 9, 2019 – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the EndoPredict® test (EPclin) identifies women with early-stage breast cancer who can safely forgo extended endocrine therapy five years after diagnosis.

Aiming to simplify and speed up complicated radiology workflows, NVIDIA and King’s College London today announced they are partnering to build an AI platform that will in the near future allow specialists in the U.K.’s National Health Service (NHS) to train computers to automate the most time-consuming part of radiology interpretation.

In the recently published 2018 annual report, Watson-Marlow Fluid Technology Group (WMFTG), a Spirax-Sarco Engineering Company, reported excellent sales of over £265 million, driven by the continued growth of key industries as well as aggressive overseas expansion.